Latest News

Huntington disease prevention trial shows creatine safe, slows progression

The first clinical trial of a drug intended to delay the onset of symptoms of Huntington disease reveals that high-dose treatment with the nutritional supplement creatine was safe and well tolerated by most participants. In addition, neuroimaging showed a treatment-associated slowing of regional brain atrophy, evidence that creatine might slow the progression of presymptomatic disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • How smells stick to your memories: Your nose can be a pathfinder

  • Cancer drugs block dementia-linked brain inflammation, study finds

  • How kids' brain structures grow as memory develops

  • Collaborative care model manages depression, anxiety in patients with heart disease

  • Shared decision making improves patient satisfaction during radiation therapy, may help alleviate anxiety, depression

  • Outcome of stroke worse for people with infection

  • New therapy helps to improve stereoscopic vision in stroke patients

  • MRI pinpoints region of brain injury in some concussion patients

  • SSRI use during pregnancy linked to autism and developmental delays in boys

  • Brain changes associated with casual marijuana use in young adults: More 'joints' equal more damage

  •